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3	 Pharmaceuticals	in	sewage	systems	and	surface	waters	–	status	quo	
3.1	 Introduction
3.1.1	 Background
This Chapter summarises new findings and insights relating to the 
occurrence of pharmaceuticals in the environment. With the introduction of 
the ‘Watch List’, which now features several pharmaceuticals (Table 3.1), 
a quantitative understanding of sources, available dilution and resulting 
concentrations of pharmaceuticals occurring in the aquatic environment 
remains important. Surface water measurement campaigns in the partner 
countries provide a useful ‘snapshot’ of levels of pharmaceuticals found 
in environmental waters, whereas waste water treatment plant (WWTP) 
influent and effluent concentrations, especially in combination with flow 
data, offer insights into the load discharged into the environment and 
dilution required to keep environmental concentrations below target levels, 
should these be set in the future. Sewage sludge is in some countries 
spread on agricultural land in the interest of nutrient cycling. Effects of 
pharmaceuticals on grazing animals have been established by Bellingham 
et al. (2012). Section 3.2 reports on concentrations and loads encountered 
in the course of our sampling campaigns in WWTP, rivers and sludges, 
including on the effect of stabilisation treatments on concentrations and 
partitioning of pharmaceuticals in sludge.
 
Name	of	substance/group	of	substances CAS	number(1)
17-Alpha-ethinylestradiol (EE2) 57-63-6 200-342-2
17-Beta-estradiol (E2), estrone (E1) 50-28-2, 53-16-7
Diclofenac 15307-86-5
Macrolide antibiotics: erythromycin, clarithromycin, azithromycin 114-07-8, 81103-11-9, 83905-01-5
Table 3.1:    Pharmaceuticals on the ‘Watch List’, adapted from EC (2015)
Whilst the introduction of environmental quality standards for single 
substances, such as via the Directive on Environmental Quality Standards 
(Directive 2008/105/EC), offers some protection for environment, it does not 
fully account for the complexity of ecosystems and toxicity effects. Whole 
sample toxicity testing is complementary to pharmaceutical analysis; it 
can flag up mixture effects such as concentration additivity and take into 
account toxicity of unknown metabolites. Section 3.3 reports on ecotoxicity 
analysis of wastewater and surface water samples. Section 3.4 concerns 
antibiotic resistant bacteria (ARB); subsequent to our findings in the PILLS 
project (PILLS, 2012), concerns over ARB have received considerable 
attention in the press and in public policy. Wastewater, and in particular 
hospital wastewater, can be a significant source of multi-resistant bacteria 
(Stalder et al. 2013) and as such constitute a pathway for such organisms 
into the natural environment. 
www.no-PILLS.eu 25
3.1.2	 The	sampling	campaigns
This section focuses on the sampling campaigns in conventional wastewater 
treatment plants and surface waters. Hospital sampling campaigns were also 
conducted; these are mentioned below but reported on in full in Chapter 6. 
In Germany, sampling took place at the influent and effluent of centralised 
WWTP Dülmen on 8 occasions, as well as upstream and downstream 
from the WWTP in the receiving water, the Tiberbach. A separate sampling 
campaign was carried out at the dedicated hospital wastewater treatment 
plant (HWWTP) Marienhospital, which is also described in full in Chapter 6.
In France, the participating HWWTPs is dedicated to Hospital Center of 
Alpes-Leman (CHAL France), whereas the WWTP treats effluent from the 
nearby urban area (Figure 3.1). The WWTP and HWWTP are on the same 
site and have a combined discharge into the river Arve. Influent samples 
were taken at the discharge of the hospital, from the effluent outlet of the 
HWWTP, in the urban sewer and after the urban WWTP. In addition, samples 
were collected from the River Arve upstream and downstream of the 
treated effluent discharge pipe. Samples were collected on three separate 
occasions: November 2013, and March & September 2014.
In Luxembourg, monitoring of wastewater at the partner hospital Centre 
Hospitalier Emile Mayrisch (CHEM) and the downstream municipal WWTP 
Schifflange took place over the time period of 28th April 2014 to 8th June 
2014. It was implemented in parallel to a urine separation campaign in 
radiology department of the CHEM (see chapter 5). The time period was 
chosen because it was exclusively out of school holiday periods and 
standard working conditions were expected on the level of the radiology 
department involved in the urine separation campaign.
In Scotland, sampling took place at the influents and effluents of two 
WWTP, one using mainly trickling filter technology (TF) and one using 
mainly conventional activated sludge technology (CAS), and upstream and 
downstream in the receiving waters. For each WWTP, two 4-day sampling 
campaigns were undertaken, one in a dry week and one in a wet (rainy) 
week. In addition, samples were taken from 7 locations in the River Almond 
catchment on 4 consecutive days to gain an understanding of spatial 
variation in the catchment.
Figure 3.1: Location of sampling points at SIPIBEL Site
Figure 3.2:  Schematic representation of the River Almond catchment with WWTP locations and sampling locations
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Table 3.2 gives an overview of participating conventional treatment works.
Participating	treatment	works Treatment	technology
Luxembourg – WWTP Schifflange CAS
Germany- WWTP Dülmen CAS 
Scotland – WWTP 1 TF (+ CAS as tertiary treatment for 20% of effluent)
Scotland – WWTP 2 CAS (+ TF as tertiary treatment)
France – WWTP SIPIBEL CAS
Table 3.2:    Participating conventional treatment works
3.2	 Loads	and	concentrations	in	wastewater,	treated	effluent,	surface	water	and	sludge
3.2.1	 WWTP	influent	and	effluent	concentrations
A number of pharmaceutical compounds were selected for transnational 
comparison of occurrence in various environments: atenolol, carbamazepine, 
ciprofloxacin, clarithromycin, diclofenac, erythromycin, ibuprofen, naproxen 
and sulfamethoxazole. 
Comparing the range of concentrations found at influent and effluent (Figure 
3.3), it can be observed that whilst in the influent the analgesics naproxen 
and ibuprofen dominate, in the effluent erythromycin and diclofenac are 
found in the highest concentrations. These two compounds also showed 
the most variation in removal efficiency between the investigated treatment 
plants. Most of the compounds investigated are present in effluent in 
ecotoxicologically relevant concentrations. The Predicted No Effect 
Concentration (PNEC) is a measure of aquatic toxicity and indicated by a red 
line for each compound in Figure 3.3. It should be noted that PNEC is not 
the only factor to be considered in determination of safe levels; other issues 
such as the potential to bioaccumulate and persistence in the environment 
are also relevant.
Figure 3.3: Range of influent and effluent mean concentrations (based on mean values at WWTPs in Germany, Luxembourg and Scotland) (µg/l), with indication of Predicted No Effect  
 Concentration (PNEC). PNEC 1 values were taken from literature: Atenolol, Clarithromycin and Erythromycin from Boillot (2008), in Verlicchi et al. (2012); Diclofenac from Ra  
 et al. (2008), in Verlicchi et al. (2012); Ibuprofen from Quinn et al. (2008), in Verlicchi et al. (2012); Naproxen and Sulfamethoxazole from FASS Allmänhet (2013);  
 Carbamazepine from Ferrari et al. (2003); Ciprofloxacin from Halling-Sørensen et al. (2000). 
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A number of other interesting findings emerged:
•	 Investigating diurnal variation via analysis of two-hour composite samples 
over a 24 hour period, peaks in the load of specific pharmaceuticals received 
at a Scottish trickling filter plant (approx. 5000 population equivalent (PE)) 
appeared to correlate with the pattern of drug administration. A peak load 
was visible between 8:00 and 10:00 for atenolol, normally taken once a 
day, whilst three distinct peaks were observed for erythromycin, normally 
taken three times a day. Untreated, such diurnal variation in discharge 
rate could lead to short term peaks in river concentrations. However, 
unless combined sewer overflows are active, the treatment plant will act 
as a buffer and less variation is expected in effluent. Work on measuring 
diurnal variation in effluent is ongoing. 
•	 In Luxembourg, amoxicillin, ciprofloxacin, clarithromycin, sulfamethoxazole, 
lidocaine, diclofenac, naproxen, carbamazepine, iobitridol and iodixanol 
were all found in every influent and effuent sample at WWTP Schifflange. 
Similarly, in Scotland, during the 4-day campaign, atenolol, carbamazepine, 
erythromycin, clarithromycin, lidocaine and Ranitidine were found in all 
influent and effluent samples at WWTP 1. 
•	 In Scotland, cyclophosphamide, a cytostatic used in the treatment of 
cancer, was found in influent and effluent samples on one day of the 
sampling period, despite the fact that no hospital effluent is treated at the 
WWTP. Although cyclophosphamide is usually administered in hospital, 
patients will normally go home after treatment and therefore excrete the 
drug into community wastewater. Cyclophosphamide was not detected in 
the Scottish hospital wastewater samples during the PILLS project. 
•	 In Luxembourg, for all the substances on the common partner 
list (amoxicillin, ciprofloxacin, clarithromycin, erythromycin, 
sulfamethoxazole, diclofenac, naproxen, carbamazepine) significant daily 
variations of concentrations were observed at all monitoring locations. 
For carbamazepine, the daily concentrations culminate in the highest 
concentrations at the end of the week. This is also the case for diclofenac 
on the level of the WWTP inflow. Although for the other substances 
clear daily variation of concentrations were observed, they have no 
recognizable recurring weekly pattern. The widest ranges from maximum 
to minimum concentration were observed for clarithromycin, diclofenac 
and naproxen in hospital samples and for amoxicillin and ciprofloxacin for 
the WWTP influent and effluent samples.
•	 Of the selected compounds, carbamazepine, lidocaine and clarithromycin 
are hardly removed in the WWTPs in the study. Erythromycin was 
moderately removed in the German WWTP but poorly in Luxembourg 
and Scotland. Diclofenac was moderately removed in Luxembourg and 
Germany, but somewhat better in France and Scotland. The common 
analgesics (paracetamol, ibuprofen, naproxen) were all well removed. 
Comparing removal efficiencies with values in a review paper by Verlicchi 
et al. (2012), values were generally in good agreement with the literature; 
however, atenolol and diclofenac were removed better than suggested 
by the literature whilst clarithromycin and amoxicillin were not removed 
as well as in previous studies. An overview is provided in Table 3.3, with 
literature values for comparison. 
	
Poorly	removed	(<30%) Moderately	removed	(30-70%) Well	removed	(>70%)
Carbamazepine (18%) Bezafibrate (61%) Atenolol (38%)
Clarithromycin (40%) Ciprofloxacin (70%) Naproxen (73%)
Erythromycin (26%) Diclofenac (29%) Ibuprofen (87%)
Lidocaine Sulfamethoxazole (52%) Paracetamol (93%)
Table 3.3:     Removal of selected pharmaceuticals in the investigated conventional WWTP (literature value in brackets; from Verlicchi et al., 2012)
Summary:
•	 Analgesics are generally well removed but, due to their high 
concentrations in raw sewage, may pose a problem in CSO situations 
where they bypass treatment.
•	 A number of other pharmaceuticals are not effectively removed by 
conventional treatment.
Policy	pointers:
•	 Monitoring of sewage discharges, including those from CSO in wet 
weather situations, is recommended.
•	 Current levels of several pharmaceuticals, including macrolide 
antibiotics, in WWTP effluents in our study were well in excess of 
Predicted No Effect Concentrations and may pose ecotoxic situations 
in surface waters unless significant environmental dilution is available. 
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3.2.2	 Concentrations	in	surface	waters
The available dilution by the flow in the receiving water can have a critical 
effect on whether a discharge results in toxic situations in the river. In 
Germany, the concentrations downstream from the river were almost the 
same as the effluent concentrations, indicating the stream has a very low 
dilution capacity (around 1.2): the Dülmen plant is not the only source of 
pharmaceuticals in the Tiberbach and many compounds were detected 
upstream from the WWTP; hence, its capacity to dilute the concentrations 
in the effluent is limited. However, Erythromycin and Clarithromycin, two 
of the ‘Watch List’ compounds, were only detected downstream from the 
WWTP and for most other compounds downstream concentrations were at 
least an order of magnitude higher than upstream. Only Ciprofloxacin was 
not detected in the river at all.
In France, all pharmaceutical compounds analysed were found both 
upstream and downstream from the WWTP; as expected, concentrations 
downstream were higher than upstream. The data do not indicate the dilution 
factor as the ratio between measured effluent and river concentrations 
varies per compound.
In Scotland, the available dilution for WWTP 1 is low, but higher than in 
Germany; during dry weather, the dilution factor in Scotland was between 
2 and 6. Mean (treated) effluent concentrations in wet weather were 
around half of those during dry weather and a higher dilution rate was also 
observed. 
The dilution available at the investigated sites in Germany and Scotland 
is much lower than the default dilution factor of 10, used in the risk 
assessment method published by the European Medicines Agency (EMEA). 
Most pharmaceuticals in rivers, measured in France, Germany and 
Scotland, are in the high nanogram range, but some – notably Erythromycin 
and Diclofenac – are present in higher concentrations (Figure 3.4). It is 
important to consider concentrations in the context of toxicity; especially 
antibiotics can be toxic at very low (0.05 µg/l) concentrations. 
The most extensive river monitoring work was carried out in Scotland. The 
River Almond (West Lothian) catchment is highly urbanised; the river and 
its tributaries receive effluent from multiple WWTP as well as numerous 
smaller discharges such as from septic tanks. To investigate spatial 
variation, daily grab samples were taken at seven locations in the upper 
and middle sections of the catchment. Eleven investigated compounds were 
detected at all but one locations, at concentrations mostly in the high ng/l 
range but up to 14 µg/l (erythromycin), indicating these compounds are 
ubiquitous in the catchment. Four of these, ciprofloxacin, ibuprofen, and 
the two macrolide antibiotics erythromycin and clarithromycin recently 
added to the Watch List were consistently found at toxicologically relevant 
concentrations in several locations. Some compounds were detected in 
a small tributary upstream from any WWTP input, and, comparing two 
locations 10km apart with no WWTP effluent inputs in between, several 
compounds were detected at similar or even higher concentrations at 
the location 10 km downstream. Although further research is necessary, 
these results suggest that non-WWTW discharges (e.g. septic tanks, 
veterinary sources) may not be negligible as contributors to overall levels of 
pharmaceuticals in this small stream. 
Figure 3.4: Range of mean concentrations in surface waters (based on mean values at single locations in Germany, Scotland and France; total 11 locations)
 1) For PNEC value references, see figure 3.3.
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For one location in Scotland, the daily load was calculated from measured 
concentration and flow, using NHS prescription data, taking excretion and 
removal efficiencies from literature (Table 3.4). Despite some limitations 
(removal values from literature were not available for TF technology so 
CAS removal efficiencies were used; measured values were based on grab 
samples only), measured values were within a factor 3 of predicted values.
Of all the WWTP discharging into the investigated parts of the catchment, only 
the furthest downstream receives hospital effluent. Despite this, there was 
no clear change in the range or concentrations of pharmaceuticals detected 
downstream from this WWTP compared to those detected in locations 
further upstream, which contain effluent from non-hospital sources. 
Expected	daily	load	
in	river	in	the	Breich	
Water	tributary		
(downstream	of	WWTP),	
Scotland
(mg/day)
Measured	daily	
load	(mg/day)
Atenolol 4404 3802
Bezafibrate 285 133
Carbamazepine 195 462
Clarithromycin 916 503
Lidocaine nda 216
Table 3.4:   Comparison with predicted concentrations. 
                  a: due to uncertainty over both the route of administration and the amount  
                  sold over the counter for Lidocaine, no predicted value could be calculated
Summary:
•	 Pharmaceuticals are ubiquitously present in the environment.
•	 Some, including macrolide antibiotics, are present in ecotoxicologically 
relevant concentrations.
•	 A clear increase in concentrations is observed after sewage effluent 
enters the river.
•	 The available environmental dilution is an important factor in the risk 
ensuing from effluent concentrations; where multiple discharges 
enter the same surface water the dilution capacity can be less than 
suggested by flow volumes.
Policy	pointers:
•	 There are indications that non-WWTP sources may contribute 
significantly to pharmaceutical loads in the aquatic environment. 
Further research is needed to verify this and to determine the 
relevance of other sources, as actions to upgrade WWTP may not 
always be sufficient to protect the environment.
•	 As our measurements indicate that some of the macrolide 
antibiotics on the ‘Watch list’ are present in sufficient quantities to 
pose an actual environmental risk, more extensive monitoring of 
these compounds is recommended.
•	 Risk assessments should where possible consider realistic available 
dilution and take account of multiple inputs as cumulative loads.
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3.2.3	 Concentration	in	biological	sludge	and	impact	of	stabilization	treatment	on	the	fate		
of	pharmaceutical	compounds	in	hospital	sludge	
Removal pharmaceutical in biological processes could be due to volatilisation, 
biodegradation and sorption on sludge. In this last case, pharmaceuticals are 
still present at variable concentration and could contaminate soils in case 
of agricultural application. Via soils, compounds could furthermore enter 
groundwater or surface waters (Lachassagne, 2014). It is then important to 
know the concentrations and the stability of pharmaceuticals during sludge 
stabilisation processes, before land spreading. 
The behaviour of 11 pharmaceutical compounds was investigated during 
the treatment of sludge from hospital wastewater (SIPIBEL France): 
carbamazepine* (CBZ), ciprofloxacin* (CIP), sulfamethoxazole* (SMX), 
salicylic acid (SAL), ibuprofen (IBU), paracetamol (PAR), diclofenac* (DIC), 
ketoprofen (KTP), econazole (ECZ), atenolol (ATN) and propranolol (PRP). 
Thickened activated sludge was subjected to two different stabilisation 
treatments: anaerobic digestion and liming, before lab scale agricultural 
application (Figure 3.5). Modification of biochemical properties of sludge 
after stabilization are reported in Table 3.5. 
1 * noPills substances
Liming	 Anaerobic	digestion	
•	 The protein concentration is higher in the soluble fraction of the limed 
sludge, probably due to cell lysis of the microorganisms present in the 
sludge due to the pH increase taking place during the liming.
•	 Digested sludge was mainly constituted of humic-like substances. 
•	 The soluble fraction was mainly composed of carboxyl groups and the 
particulate fraction of phosphoric and amine groups. 
•	 Phase distribution of pharmaceutical compounds showed that 
carbamazepine and ibuprofen were mainly in the soluble fraction, so 
could be more available after landspreading.
•	 Sulfamethoxazole was the only compound removed during anaerobic 
digestion.
Table 3.5:    Summary of the effects of stabilization steps on biochemical composition of hospital sludge.
Figure 3.5: Different stages of hospital sludge treatment, stabilization and application (GDD: drip grid)
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Figure 3.6 shows that the concentrations of pharmaceutical compounds 
in the sludge after stabilization by liming or anaerobic digestion were very 
different depending on the specific compound. Whatever treatment applied, 
among these molecules, Ciprofloxacin had the highest concentration 
in the sludge, whilst econazole had the second highest concentrations. 
Ciprofloxacin concentrations are not shown; they vary between 4.05 and 
1.5 during liming and between 4.05 and 1.0 during anaerobic digestion)
Organic micropollutants behaviour during sludge treatment is linked to 
specific interactions between functional groups of sludge structure and 
those of the compounds. The pKa of functional groups such as carboxyl, 
amine, phosphate and hydroxyl characterises these interactions, which are 
partially responsible for the sorption of pharmaceutical compounds onto 
sludge.
Proton binding site concentrations and corresponding pKa values 
were assessed in soluble and particulate fractions by a combination of 
potentiometric tritrations. Activated, thickened, limed and digested sludges, 
showed four groups of pKa values in particulate and soluble fractions, which 
can be attributed to the following functional groups of components: pKa1 
and pKa2 to carboxylic group, pKa3 to phosphoric group and pKa4 can be 
attributed to amine and/or hydroxyl groups.
The functional group distribution in the particulate fraction of activated, 
thickened and digested sludges was similar, except for the carboxyl group 
distribution which was lower for the particulate fraction of digested sludge. 
In the soluble fraction, the distribution of each group of components was 
different between the three kinds of sludge. Indeed, the distribution of 
carboxyl groups was less important for thickened sludge (10 %) than for 
activated (50 %) or digested (65 %) sludge. Regarding digested sludge, 
the distribution of carboxyl groups was more important in the soluble 
fraction. Carboxyl groups can be linked to proteins, humic-like substances 
and uronic acids. Amine groups were mainly present in proteins whereas 
hydroxyl groups originate essentially from polysaccharides and humic-like 
substances. 
The two different stabilisation treatments have different effects on the 
partitioning of the pharmaceutical compounds in the sludge. The phase 
distribution of pharmaceutical compounds in soluble and particulate fractions 
of hospital sludge after stabilization was determined and presented in table 
3.6. Sludge stabilization treatment (liming or anaerobic digestion) processes 
did not lead to a complete elimination of pharmaceutical compounds; only 
phase distribution of compounds changed between the two parts of the 
sludge during the treatment.
Figure 3.6: Evolution of pharmaceutical compounds concentrations during hospital sludge stabilization processes: liming (a) and anaerobic digestion (b).  
 BE-H : hospital Thickened Sludge, BCh-H : Hospital limed Sludge, BD-H: Hospital Digested Sludge. The concentrations are expressed in µg/gTS.
(a) (b)
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Compound Limed	hospital	sludge Digested	Hospital	Sludge
% particulate % soluble Kdsorption (L/kg) % particulate % soluble Kdsorption (L/kg)
Carbamazepine 51.2 48.8 36.9 47 53 50.4
Ciprofloxacin 80.3 19.7 143 92.5 7.5 698
Sulfamethoxazole 100 0 8265b N.d.a N.d.a N.d.a
Salicylic Acid N.d.a N.d.a N.d.a N.d.a N.d.a N.d.a
Ibuprofen 0 100 0 0 100 0
Paracetamol 100 0 4065b 100 0 2643b
Diclofenac 70.5 29.5 84 0 100 0
Ketoprofen N.d.a N.d.a N.d.a 0 100 1193b
Econazole 100 0 42 465b 100 0 52 443b
Atenolol N.d.a N.d.a N.d.a N.d.a N.d.a N.d.a
Propranolol 100 0 743 298b 57.7 42.3 77.6
Table 3.6:      Particulate-soluble pharmaceutical compounds repartition and Kdsorption values for limed and anaerobically digested hospital sludge
                     a: N.d = Not determined, because the compound was not detected in the total sludge
                     b: Kdsorption is maximum (even infinite). In those cases where the concentration in the soluble phase is less than the detection limit, 
                         the value of the detection limit was used for calculation. 
                     Regarding phase distribution and stabilization process, different behaviours for all compounds are summarized table 3.7.
Liming	 Anaerobic	digestion	
Pharmaceutical compounds were present at concentrations less than 
0.5 μg / gTS with the exception of ciprofloxacin. Overall, liming causes 
a reduction of the drug content, except for sulfamethoxazole, diclofenac 
(hospital sludge) and econazole .
Regarding phase distribution, differences in behaviour between all these 
compounds was observed. Carbamazepine was equally distributed in 
the soluble and particulate fractions of sludge. Paracetamol, econazole, 
propranolol and sulfamethoxazole were mainly in the particulate fraction, 
whereas ibuprofen was mainly in the soluble fraction.
The drug concentrations are less than 0.5 μg / gTS, except for salicylic 
acid which is present at a concentration of 1.2μg / gTS in urban 
sludge. Sulfamethoxazole was the only compound that was completely 
disappearing after anaerobic digestion while carbamazepine was still 
present after treatment. 
In digested sludge, all the ibuprofen was present in the soluble fraction. 
This compound could be more likely desorbed into the soil if the sludge 
is used for landspreading. Carbamazepine and propranolol were equally 
distributed between the particulate and soluble fractions, Ciprofloxacin, 
paracetamol and econazole were mostly in the particulate fraction, and 
ibuprofen, Diclofenac and ketoprofen were mainly in the soluble fraction.
Table 3.7:     Impact of sludge stabilization treatment on pharmaceutical phase distribution
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The organic compounds (in this case pharmaceuticals) are sorbed to 
sludge partly by hydrophobic type interactions, but mainly by electrostatic 
interactions. Microorganisms present in the sludge have a negative surface 
charge and act as cation exchangers, which causes a strong interaction 
between the micro-organisms’ surface and positively charged compounds 
at the typical pH of sludge, such as carbamazepine or atenolol. However, it 
appears that hydrophobic interactions play a role for the positively charged 
compounds. In addition, at a typical pH for wastewater, compounds having 
a high log Kow, such as diclofenac and ketoprofen, are mainly negatively 
charged (ionized form) and will tend to be present in the aqueous phase, 
whereas compounds having a low logKow are mainly present in the 
particulate phase (Lachassagne, 2014).
In conclusion, hydrophobicity (log Kow) cannot by itself explain the sorption 
behaviour of sludge and the soluble / particle distribution of micropollutants. 
The functional groups present in sludge at each stage of processing also 
play an important role in the interactions.
3.3	 Environmental	ecotoxicity	evaluation	
3.3.1	 Introduction
When chemical compounds are developed to enter the EU market, their 
potential fate and effect in the environment is assessed under the EU 
REACH regulation. The testing is focused on evaluating the toxic effects 
on humans and ecosystems, and their fate in the environment: persistence 
and bioaccumulation in the food chain. When chemicals are very toxic, or 
are not degraded in the environment, leading to increasing environmental 
concentrations, or when they accumulate in the food chain, leading to high 
concentrations in the top predators, measures to prevent release of the 
chemicals into the aquatic environment may be required or the marketing 
authorisation can be denied. As some of the most potent pharmaceuticals 
may be used in low doses, total tonnage may be below REACH thresholds. 
Furthermore, if an environmental risk for pharmaceuticals is identified, 
certain mitigation proposals may be required, but a marketing authorisation 
will not be denied (BIO Intelligence Service, 2013). Pharmaceutical residues 
enter the environment, either as a result of excretion from the human body, 
or as a result of discharge of medicine waste, and can include very toxic 
(e.g. cytostatics) or very persistent (e.g. X-ray contrast agents) compounds. 
Although pharmaceuticals are produced to heal humans, Paracelsus knew 
already in the 15th century that “Dosis facit venenum”, “The dose makes 
the poison”. If the concentration of a medicinal compound in a body is too 
high, it will act as a toxic compound. This is the same in the environment 
where the wide range of creatures exposed will respond differently, thus it is 
important to evaluate the toxicity of pollutants or polluted environments with 
a range of test organisms. We know that the toxic dose of one compound for 
different environmental organisms may vary by more than a factor 1000; in 
general smaller organisms are more sensitive than bigger organisms due to 
their larger surface-to-volume ratio. When determining the environmental 
toxicity of a drug the mode of action should also be considered as the target 
receptors and enzymes may affect different species in different ways. 
Furthermore, the effects of long term exposure to a compound may appear 
at lower concentrations than a one-off exposure to a high environmental 
concentration that disappears quickly. 
Whole sample ecotoxicity testing exposes test organisms to the mixture of 
all chemicals present in the sample. Toxicities of individual compounds may 
be synergistic or antagonistic; whole effluent toxicity is almost impossible 
to predict as an ever-changing mixture of thousands of compounds is 
present in sewage effluent. Mixture toxicity has been investigated for few 
compounds only (e.g. Christensen et al., 2007; Cleuvers, 2004). Ecotoxicity 
testing as described below therefore offers vital complementary data to the 
chemical analytical data on single pharmaceutical concentrations. 
Summary:
•	 Pharmaceuticals are partly sorbed to sludge by hydrophobic type 
interactions, but mainly by electrostatic interactions (Lachassagne, 
2014). 
•	 Stabilisation processes during sludge treatment could modify these 
interactions depending on the process. Molecules can then become 
available and can reach water bodies.
Policy	pointers:
•	 Potential contamination of sludge during biological treatment and 
stability of sorption has to be considered in the overall balance of 
removal and in decision making on the use of sludge.
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3.3.2	 Ecotoxicity	testing
The ecotoxicity of collected wastewater samples was assessed using a battery of tests (Table 3.8).
Country/
Evaluation
Scotland France	
Acute toxicity Bacteria 
 
Algae 
 
Fish
Aliivibrio fischeri  
(ISO 1348-3)
Raphidocelis subcapitata
Danio rerio
Crustacean Daphnia magna (ISO 6341)
Chronic toxicity Fish Danio rerio Algae
Crustacean
Rotifer
Pseudokirchneriella sub-
capitata (ISO 8692)
Heterocypris incongruens 
(ISO 14371)
Brachionus calyciflorus 
(ISO 20666)
Genotoxicity Bacteria
Mammalian cells
SOS chromotest 
single cell comet assay
Mutagenicity Fish Danio rerio Fish Danio rerio
Endocrine disruptors Human cell line Estrogenic activity (MELN 
cell line)
Table 3.8:     Test organisms utilized during the evaluation of wastewater samples plus relevant ISO standard followed or in-house protocols followed.
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Of the two WWTP’s monitored, the trickling filter treatment facility yielded 
the largest number of acutely toxic samples compared with the activated 
sludge treatment facility (Table 3.10). This observation can partially be 
accounted for the increased toxicity of the influent samples reaching the 
trickling filter facility compared to those entering the activated sludge 
treatment facility.
Location Luminescent	bacteria
(Aliivibrio fischeri) 
Zebrafish
(Danio rerio)
River 21.9 21.9
WWTP Influent 72.7 45.5
WWTP Effluent 36.4 36.4
Table 3.9:     Percentage of samples defined as being toxic to the test organism. Collated data for 2 treatment works, ntotal = 11.
Primary	sewage	treat-
ment
Sampling	Location Number	of	samples	(n) Luminescent	bacteria	
(Aliivibrio fischeri) 
Zebrafish
(Danio rerio)
Weather condition: low rainfall (total 5.6mm TF; 5.5mm AS during campaign)
Trickling filter Influent 4 100.0 25.0
Effluent 4 50.0 50.0
Activated sludge Influent 3 33.3 0.0
Effluent 3 0.0 0.0
Weather condition: high rainfall (total 9.1mm TF during campaign)
Trickling filter Influent 4 75.0 75.0
Effluent 4 50.0 50.0
Table 3.10:    Effect of treatment within WWTP and of rainfall on samples defined as being toxic to the test organism (percentage of samples).
3.3.3	 Outcomes
Scotland	
Of the 99 samples evaluated using the inhibition of Aliivibrio fisheri 
luminescence, 45 % were defined as acutely toxic and 55 % as not acutely 
toxic (i.e. where there was no decrease in relative light units after 30 mins). 
The maximum inhibition recorded was 28 %, in WWTP influent. Thirty five 
percent of the samples were considered as toxic to Danio rerio embryos as 
judged by mortality (Table 3.9). Pre-concentration of the samples utilizing 
freeze-drying as the enhancement step continues to be investigated. 
Toxicity evaluation utilizing algae is still on-going. 
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France	
A range of ecotoxicity assays were used to characterize the environmental 
impacts of a samples entering and leaving the WWTP associated with the 
monitored hospital (Table 3.11). The toxicity of the hospital effluent changed 
with time, with the spring 2014 sample being considered the most toxic. 
The whole organism toxicity (either acute or chronic) and the endocrine 
disruptor evaluation appeared to be the useful measures, however, to 
characterize the environmental impacts of a sample of water a battery of 
assays are required. A major reduction in the ecotoxicity of the effluent was 
noted after treatment.
Assessment Outcome	
measure	
Hospital	
effluent
After	WWTP Hospital	
effluent
After	WWTP Hospital	
effluent
After	WWTP
November 2013 March 2014 September 2014
Acute toxicity
Crustaceans
Daphnia magna 
EC50 (%) 56.6 >90 8.3 >90 56.6 >90
Chronic toxicity
Freshwater Algae
Pseudokirchneriella 
subcapitata
EC20 (%) 19.9 >80 15.7 68.7 19.9 >80
Rotifer
Brachionus calyciflorus
EC20 (%) 61.5 100 6.8 100 61.5 100
Ostracode
Heterocypris incongruens
Growth  
inhibition (%)
39.9 0 59.0 0 39.9 0
Genotoxicity & Mutagenicity
Comet assay Tail DNA (%) NS NS NS NS NS NS
SOS chromotest Induction 
factor
2.0 1.5 1.7 1.8 2.0 1.5
Micronucleus number of 
nuclei
14.0 1.7 25.0 4.0 14.0 1.7
Endocrine disruptors
Thyroid hormone ng/l EqT3 NS NS NS NS NS NS
Estrogens ng/l EqE2 30.5 0.14 14.0 0.12 30.5 0.14
Estrogens ng/l EqE2 30.5 0.14 14.0 0.12 30.5 0.14
NS:- not significant  
Table 3.11:      EC50 concentrations indicating ecotoxicity of the hospital effluent before and after the WWTP (as percentage of the concentration measured in the sample)
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The tests used were not sensitive enough to measure neither the 
background toxicity nor the impact of the effluent in the river Arve due to 
dilution of toxic compounds. Only the assessment of the chronic ecotoxicity 
using ostracode and rotifer and the evaluation of the endocrine disruptors 
yielded measurable results during two of the three monitoring periods.
3.4	 Antibiotic	Resistance
3.4.1	 Introduction
The discovery and use of antibiotics in modern medicine has undoubtedly 
contributed to the increase in life expectancy observed in the latter part 
of the 20th century. However, from the 1940s, the first cases of resistant 
strains were identified (sulfonamides 1939, penicillin 1941). The occurrence 
of these strains has resulted in the design of new molecules, but this 
forward march reaches its limit with the increase of resistant bacteria. The 
consequences are increased morbidity and mortality (estimated 25,000 
deaths / year in Europe) but also the associated costs (additional cost 1.5 
billion € / year) (Chomarat et al. 2014). Thus, control of antibiotic resistance 
in hospitals as well as in the community, has become a priority issue in 
public health in many industrialized countries and a priority for the World 
Health Organisation (WHO, 2015).
The emergence of antibiotic resistance phenomena is related to adaptive 
pressure process of germs to the presence of antibiotics. These phenomena 
are mostly due to horizontal transfer of genes, by exchange of mobile 
elements (plasmids, transposons, integrons) (Stokes and Gillings, 2011; 
Buckley, 2009) and via different phenomena (transformation, conjugation, 
transduction). This horizontal gene transfer probably occurs in all terrestrial 
ecosystems colonized by bacteria.
In recent years, particularly since the end of the European research program 
“Pills”, the consideration of resistant bacteria carried by wastewater 
effluent, even treated, or hospital effluents, increased, with concern about 
the dissemination of bacterial resistance, and gene transfers that may 
accompany it. A significant number of publication states the presence 
of the Antibiotic Resistant Bacteria (ARB) along an aquatic continuum or 
watershed (Allen et al., 2010; Baquero et al., 2008; Wright et al., 2007; 
Schwartz et al., 2003; Novo et al., 2010). 
The results in this study come from French locations. Antibiotic consumption 
in France remains above average in Europe and the United States. Between 
2000 and 2013, antibiotic consumption declined by 10.7%, but increased 
by 5.9% since 2010 with 32.3 Defined Daily Doses /1000 Inh/Day. In terms 
of volume, over 90% of consumption of antibiotics is in the community 
and slightly less than 10% in the hospital. Exposure to antibiotics is high 
hospitals; on any given day about 4 out of 10 patients receive a dose of 
antibiotics (ANSM- French National Agency for Medicines Safety, 2014).
Summary:
•	 Conventional WWTP are effective in reducing ecotoxicity levels but 
some toxicity remains.
•	 The most toxic WWTP effluent was that of the Trickling Filter plant. 
This may be partly ascribed to high influent concentrations. 
•	 Over 20% of Scottish river samples were acutely toxic to aquatic 
organisms, indicating high pollution levels. However, it must be noted 
that it is not certain that the toxicity is due to pharmaceutical content.
Policy	pointers:
•	 Research into the pharmaceutical contribution to toxic effects in 
surface waters is recommended.
•	 Research on ecotoxicological tests has to be improved to define the 
most relevant environmental impact(s) for monitoring.
•	 It is recommended that ways to assess whole effluent ecotoxicity 
(such as e.g. via biomarkers), should be considered for possible future 
standards, in order to account for full complexity of the mixture.
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3.4.2	 Determination	of	Antibiotic	Resistant	Bacteria	
One of the difficulties in the analysis of antibiotic resistance is the choice of 
the method of determination, and, especially as the matrix in which occurs 
this research is complex (e.g. effluents, manure, soil). It is now recognized, 
and Pills program has contributed to this, that the search for Resistance 
Integrons (RI) is an approach contributing to an overall reliable and relatively 
simple estimation of antibiotic resistance. RI are genetic elements involved in 
acquisition, storing, and expression of antibiotic resistance genes embedded 
within a gene cassette, composed of a intl gene encoding an integrase 
protein, a specific recombination site attl, and a promoter, Pc. These RI 
are not self-transposable elements but are often located on plasmids or 
transposons, which promote their dissemination among bacteria.
Thus, the assessment of the amount of integration (concentration or relative 
abundance) is able to quantify and / or qualify the occurrence of antibiotic 
resistance, by molecular biology methods. The quantification of integrons 
was done in the same manner and with the same developed method as in 
Pills project (PILLS, 2012; Stalder et al., 2014).
All results are expressed either in concentration, representing the 
prevalence of RI in a given bacterial population, or in relative abundance, 
corresponding to the RI concentration divided by the estimated number of 
bacteria (calculated by dividing the number of 16S-rRNA-encoding gene per 
the average quantity of 16S-rRNA-encoding-gene per bacteria (4.1 gene 
per bacteria)).
The different samples collected from the different sites during the Pills 
and noPills programs clearly showed the specificity of hospital effluents 
compared to urban effluent, to other anthropic effluent, and to natural water 
(figure 3.7B). This is especially true if we consider the Relative Abundance 
(figure 3.7A). 
3.4.3	 Monitoring	ARB	
The pilot site of Bellecombe (SIPIBEL)
Located on the department of Haute-Savoie (Figure 3.8), near the Swiss 
border, the pilot site (described in Chapter 3.1) consists of:
•	 The Hospital Center of Alps Leman (CHAL) commissioned in February 
2012, with a capacity of 450 beds;
•	 A wastewater treatment plant (WWTP) of Bellecombe with two separate 
processing lines one for the urban effluent, one for the CHAL, closed to 
the WWTP;
•	 A receiving water: Arve River, which supplies water for human 
consumption in Geneva.
Figure 3.7: Relative abundance and concentration of Resistance Integrons in various samples (GER Germany, NL Nederland, SCO Scotland, FRA France, LIM Limoges,  
 AN Annemasse, GLA Glasgow, TOR River.
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A biological treatment system of activated sludge for 5400 population 
equivalent (PE) is dedicated exclusively to the treatment of hospital 
wastewater. 
Prior to the opening of the facility in 2012, effluent samples discharging into 
the river were analysed. 
Dynamic	evolution	on	the	investigated	catchment	area	
Resistance Integrons (RI) were monitored and Relative abundance (RA) 
calculated during 3 years on SIPIBEL. Regarding the relative abundance, the 
cumulative results showed that:
The RA in the effluent discharged by the hospital was significantly higher 
than those of the urban effluent (figure 3.9), however the data was highly 
variable.
As in the last study, RA in urban wastewater was very low and statistically 
equal to those of the river, even downstream. 
The wastewater treatment plant treating the hospital effluent showed a 
significant decrease in RI. This is likely due to a conventional removal of the 
number of bacteria (2-3 log), but for hospital effluent, these bacteria were 
multi-resistant.
Figure 3.8: Localisation of SIPIBEL
Figure 3.9: RA in different samples: influent and effluent of the urban and hospital WWTPs and Arve river.
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The evolution of RI and RA in the hospital effluent before and after treatment 
is reported in Figure 3.11 and compared to the urban effluent at the same 
time, and over a three year period. 
It is noted that the evolution of RI and especially of the RA is constantly higher 
in the effluent from the hospital than in the urban effluent. It is confirmed 
that the output values of the two treatment plants, urban or hospital, are 
The Bray-Curtis similarity index was used to analyse qualitatively the 
similarity between samples in terms of both gene cassette diversity and 
gene cassette arrays. We found (Figure 3.10) that the urban effluent and 
WWTP influent were most similar, while the hospital effluent and the 
recirculation sludge exhibited very specific patterns, showing the specificity 
of hospital effluent in term of resistance to antibiotics. 
statistically comparable during the entire time of the experiment. One 
diminution is relatively standard compared to the bacterial elimination in 
a WWTP (2 to 3 log). The number of RI spread into the environment from a 
wastewater treatment plant is approximately proportional to the bacterial 
content and similar between hospital and urban effluents. 
Figure 3.10: Index of Bray-Curtis for (A) the gene cassettes diversity, and (B) the gene cassettes pool. UE, urban effluent, HE hospital effluent, WI, influent WWTP, 
 WE effluent WWTP, RS, sludge.
Figure 3.11: Concentration of RI (2) and RA (1) during the noPills Programme
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3.4.4	 Concluding	remarks
Worldwide, national governments have embarked on numerous initiatives to 
reduce risks from antibiotic resistance, e.g.: 
•	 French ‘Roadmap 2015’ of the Ministry of Ecology “…on reducing health 
risks by assigning a expert mission to ANSES (French Agency for Food, 
Environmental and Occupational Health & Safety)
•	 French Ministry of Health coordinated the preparation of a technical guide 
“for waste management (from drugs – liquids) by the health and social 
service institutions” to be published in 2015.
•	 UK Department of Health Antimicrobial stewardship initiative (DOH, 2011)
•	 Key measures proposed by the European COST TD 0803 (see Berendonk 
et al, 2015)
•	 The United States of America proposed “a national action plan for 
combating antibiotic-resistant bacteria” (TWH, 2014) 
•	 At EU level, macrolide antibiotics have been added to the ‘Watch list’ 
(erythromycin clarithromycin, azithromycin) (European Commission, 
2015)
Areas of research and development include the development of rapid 
diagnostic techniques, the development of new antibiotic drugs, 
improvements in waste and wastewater management, and understanding 
and control of pathways of resistance. Many initiatives have been 
undertaken, but given the potential crisis to come, much research and 
development remains to be done to protect public health.
Summary:
•	 Sewers collect wastewater, which comes from homes or care centres, 
and may contain a resistant bacteria load. The relative abundance 
of resistant bacteria in a hospital effluent is higher than in an urban 
effluent.
•	 The quantification of integrons and relative abundance could 
be a method to evaluate an overall resistance before a specific 
identification with molecular technique.
Policy	pointers:
•	 The fight against antibiotic resistance requires a range of approaches, 
which could include: 
 ○ The standardization of quantification methods 
 ○ The definition of indicators to monitor ARB –such as integrons used 
in this study 
 ○ The definition of a methodology for risk assessment
 ○ The evaluation of gene transfers in anthropic systems
•	 Control of resistant bacteria at source could play a role in maintaining 
effectiveness of antibiotic treatments.
•	 Fundamental research of resistant bacteria and gene transfer is 
recommended.
